BioTork is a biotechnology company founded in 2008 that specializes in the optimization of industrial fermentation processes. BioTork provides robust microorganisms that are able to convert low-value, raw carbon sources such as agroindustrial by-products and waste into high-value chemical commodities. These biochemical commodities such as omega-3 oil, lipids, fuels, enzymes, plastics and other compounds are derived from renewable feedstock using a continuous culture technology.
Technology
BioTork has an exclusive license with Evolugate, a technology provider specializing in adaptive evolution technology that is a continuous culture apparatus which selects the fittest genetic variants from a certain population under controlled environmental conditions. After multiple stages of natural selection, the microorganisms acquire enhanced capabilities that were not present in the original strain. These new capabilities include a faster growth rate, the ability to grow at non-optimal temperatures, resistance to inhibitors or growth under nutrient limiting conditions
Non-GMO
The microorganisms that are evolved with Evolugate's technology are done so through natural selection, and therefore are enhanced without genetically modifying their composition. This allows for the microorganism to exist without being labelled as a GMO, and therefore circumvents issues related to food and feed regulations.
Versatile Feedstock
The technology that BioTork uses through Evolugate is able to convert unrefined, raw feedstock into several high quality resources, as mentioned before including omega-3 fatty acids and renewable chemicals. Raw carbon sources are generally renewable, often coming from biodiesel production or leftover agricultural waste. Therefore, the end-product that BioTork is left with is sustainable and inexpensive, in addition to non-GMO.
, The Chemical Company, and BioTork currently have a bioplastics development deal to industrially produce biopolymers and green-based chemicals. The main objective of this collaboration is to improve biochemical production processes through strain development. The financial details of this collaboration and partnership have not been disclosed at this time.